Results 121 to 130 of about 14,464 (157)

A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. [PDF]

Pancreas, 2019
Halperin DM, Lee JJ, Ng CS, Strosberg JR, Estrella JS, Dagohoy CG, Dasari A, Yao JC.   +7 more
europepmc   +1 more source

Ziv-aflibercept combined with intravitreal steroid for management of peripheral exudative haemorrhagic chorioretinopathy. [PDF]

BMJ Case Rep, 2019
Balakrishnan D, Oli A.
europepmc   +1 more source

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G. [PDF]

Target Oncol
Matsumoto T, Yamamoto Y, Kotaka M, Masuishi T, Tsuji Y, Shoji H, Hirata K, Tsuduki T, Makiyama A, Izawa N, Takahashi N, Tsuda M, Yasui H, Ohta T, Kito Y, Otsu S, Hironaka S, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K.   +21 more
europepmc   +1 more source

Three‐month outcomes of ziv‐aflibercept in the treatment of diabetic macular oedema [PDF]

Acta Ophthalmologica, 2016
Mohammed, Ashraf, Ahmed A R, Souka, Hassan, El Kayal, Mostafa, El Manhaly, Mohamed Hossam, Abdallah   +4 more
openaire   +2 more sources

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab

, 2018
Olga E Makri, Foteini N Tsapardoni, Panagiotis Plotas, Athina Pallikari, Constantine D Georgakopoulos Department of Ophthalmology, University of Patras, Patras, Greece Purpose: To report the 12-month outcomes of a patient switching from intravitreal ...
Tsapardoni FN, Georgakopoulos CD, Plotas P, Makri OE, Pallikari A   +4 more
core  

Treatment outcomes of ziv‐aflibercept for treatment‐naïve polypoidal choroidal vasculopathy [PDF]

Acta Ophthalmologica, 2017
Errol W. Chan, Mohab Eldeeb, Vishal Govindhari, Chintan Sarvaiya, Alay Banker, Ahmad Mansour, Jay Chhablani   +6 more
openaire   +2 more sources

Efectividad del uso de tres dosis de ziv-aflibercept intravítreo en el tratamiento del edema macular diabético en un entorno de la vida real

Objetivo: Evaluar en un entorno de la vida real la eficacia del Ziv-Aflibercept intravítreo en el tratamiento del edema macular diabético (EMD) después de la administración de tres dosis mensuales consecutivas. Métodos: Estudio de cohorte prospectivo de
Munayco Guillén, Fernando
core  

Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion

Indian Journal of Ophthalmology, 2015
Jay Chhablani
doaj   +1 more source

374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

Journal for ImmunoTherapy of Cancer, 2021
Howard Streicher, Michael Manos, Philippe Bedard, Osama Rahma, Andrew Brohl, Kevin Tyan, Scott Rodig, Daniel Renouf, Emma Hathaway, Rachel Cunningham   +9 more
doaj   +1 more source

Comment on: Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion

Indian Journal of Ophthalmology, 2015
Alok Sen, Ashish Mitra, Pawan Puneet Malhotra, Sonal Gupta   +3 more
doaj   +1 more source